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Abstract 
Objective: To analyse Potential Years of Life Lost (PYLL) rates trends of lip, oral 
cavity and pharynx neoplasms in the Slovak population by age and gender. Material 
and Methods: The study analyses PYLL rates (age-standardized) of lip, oral cavity and 
pharynx neoplasms (C00-C14) per 100,000 in the period of six years (2010-2015). The 
study sample was divided into two age sub-categories (all ages: 0-69y. and working 
group: 20-69y.) National mortality data (C00-C14) (3,138 mortality causes) were 
analysed from the Statistical Office of the Slovak Republic. Results: The highest PYLL 
rate was found in sub-category 20-69 years in males (378 per 100,000) in 2012 and in 
females (64 per 100,000) in 2013. The highest PYLL rate was observed in sub-category 
all age groups in males (296 per 100,000) in 2012 and in females (50 per 100,000) in 
2013. The PYLL rates of lip, oral cavity and pharynx neoplasms had in the period 2011-
2015 upward trend in both sexes, however, in the 2014 was found the opposite trend.  In 
2015 the highest PYLL rates (non-standardized) in both sexes was found in age sub-
category 55-59y. Conclusion: Our study should contribute to the development of oral 
cancer intervention programs. 
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Introduction 
Lip, oral cavity and pharynx neoplasms (ICD-10 codes C00-C14) are an important public 
health problem [1] with an annual worldwide incidence estimated at approximately 529,500 cases 
(3.8% of all cancer cases) and mortality at 292,300 deaths (3.6% of cancer deaths) [2]. 
In developing countries, risk factors for lip, oral cavity and pharynx neoplasms include the 
chewing tobacco, smoke tobacco, the consumption of nitrosamine-rich foods, the consumption of 
salted fish, the presence of human papillomavirus (HPV) [3] and alcohol consumption [4-7]. 
Approximately 75-80% of lip, oral cavity and pharynx neoplasms are attributed to tobacco and 
alcohol consumption [8]. In the Slovak Republic, prevalence of tobacco smoking is approximately 
20% and the alcohol consumption is 115 litters of all alcoholic beverages (beer, wine, spirits) per 
person/year [9,10]. Relationship between alcohol consumption and oral-pharyngeal neoplasms was 
described in literature [11,12]. 
As a premature mortality measure, potential years of life lost (PYLL) provides estimating the 
average years a person would have lived if population had not died prematurely. Potential years of 
life lost is one of the most used indicator for the well-being population monitoring [13,14]. 
In Europe, there are limited numbers of PYLL studies analysed of lip, oral cavity and 
pharynx neoplasms. The aim of this study is to analyse potential years of life lost rates trends of lip, 
oral cavity and pharynx neoplasms in the Slovak population by age and gender in the 6-years period 
of 2010-2015. 
 
Material and Methods 
The study sample was divided into two age sub-categories (all age groups: 0-69 years and 
working group: 20-69 years). National mortality data (C00-C14) (3,138 mortality causes) were 
analysed from the Statistical Office of the Slovak Republic. 
The PYLL rate was calculated according to the following formula [15]: 
 
PYLLit = Σ (l – a) (dat / pat) (pa / pn) * 100,000 
 
l: the population's life expectancy; i: year; dat: the deaths number; pat: population number in an age 
group; Pa: the number of standard population; Pn: the standard population number (0-69 years). 
 
Results 
The PYLL rates of lip, oral cavity and pharynx neoplasms according to gender and 
particular periods for sub-category all ages can be seen in Figure 1A and the PYLL rates for sub-
category 20-69 years can be seen in Figure 1B. In the period of 2010-2015, the highest mean PYLL 
rate was observed in males (sub-category 20-69 y.: 365 per 100,000 and sub-category all ages: 285 
per 100,000), in females (sub-category 20-69 y.: 58 per 100,000 and sub-category all age groups: 47 
per 100,000) as well as in both sexes (sub-category 20-69 y.: 212 per 100,000 and sub-category all 
age groups: 166 per 100,000). 
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Figure 1A: The PYLL rates of lip, oral cavity and pharynx neoplasms according to gender and 
particular periods, all age groups. Figure 1B: The PYLL rates of lip, oral cavity and pharynx neoplasms 
according to gender and particular periods, 20-69 ages. 
 
The highest PYLL rate was found in sub-category 20-69y. in males (378 per 100,000) in 
2012 and in females (64 per 100,000) in 2013. The highest PYLL rate was observed in sub-category 
all ages in males (296 per 100,000) in 2012 and in females (50 per 100,000) in 2013. 
The PYLL rates of lip, oral cavity and pharynx neoplasms had in the period 2011-2015 
upward trend in both sexes, however, in the 2014 was found the opposite trend. The PYLL rates 
(non-standardized) of lip, oral cavity and pharynx neoplasms according to gender and age, all ages in 
2015 can be seen in Figure 2. In 2015 the highest PYLL rates (non-standardized) in both sexes was 
found in age sub-category 55-59y. 
 
 
Figure 2. The PYLL rates (non-standardized) of lip, oral cavity and pharynx neoplasms according to 
gender and age, all ages, 2015. 
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Discussion 
Worldwide cancer is one of the public health problem. The differences in incidence of oral 
and of oropharyngeal cancer in different parts of the world reflects differences in the specific risk 
factors prevalence. A high lip cancer incidence is associated with white race exposed to solar 
radiation. High incidence rates of cancers of intra-oral sites are associated with high tobacco 
consumption [16]. Diet, nutrition, environmental factors, environmental determinants can 
contribute to the risk of oral cancer [17]. The early diagnosis of oral cancer increases the probability 
of cure and deformity [18].  
The cancers of oral cavity are classified into sub-categories: (1) upper alveolus and gingival; 
(2) buccal mucosa; (3) hard palate; (4) tongue; (5) floor of mouth; and (6) lower alveolus and gingival 
[19]. 
In 2011 according to Munich cancer registry was diagnosed 517 cases of lip, oral cavity and 
pharynx neoplasms (males: 359 casas and females: 158 cases) in Bavaria (4.5 million inhabitants) 
[20]. In the Slovak Republic (5.5 million inhibitants) was diagnosed 491 cases (males: 439 cases and 
females: 52 cases) of lip, oral cavity and pharynx neoplasms in this same year. In our country in 
females was found three times lower incidence of lip, oral cavity and pharynx neoplasms than 
Bavaria. This can be partly explained the differences in lifestyle in females.   
In Munich study the mean PYLL rates of lip, oral cavity and pharynx neoplasms in the 
period 1998-2011 was in males 128 per 100,000 inhabitant and in females 27 per 100,000 inhabitant 
[20]. In our study, the mean PYLL rates of lip, oral cavity and pharynx neoplasms in the period 
2010-2015 was in males 285 per 100,000 inhabitant and in females 47 per 100,000 inhabitant. The 
oral cancer mortality in females was lower than in males it was confirmed by the Nieto and Ramos 
study [21]. 
Our study was limited low numbers of PYLL studies (oral cancer). In the National center for 
biotechnology information database (PubMed) it was found only one PYLL oral cancer study [21] 
with the help of key words "oral cancer and PYLL". 
 
Conclusion 
In the Slovak Republic, the highest PYLL rate of oral cancer was found in sub-category 20-
69 years and in sub-category all age groups in both sexes in 2013. In the PYLL rates of oral cancer 
was found rising trend in both sexes in the period 2011-2015, however, in the 2014 was found the 
opposite trend. In 2015 the highest PYLL rates of oral cancer (non-standardized) in both sexes was 
found in age sub-category 55-59y. 
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